Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

Development Status

Other

1

Possibly Marketed Outside US

1

All Match

Any Match

Exclude Selected

Exclude Selected

Primary Target

sulfite oxidase

1

All Match

Any Match

Exclude Selected

Exclude Selected

Highest Phase

Not Provided

1

All Match

Any Match

Exclude Selected

Exclude Selected

Approval Year

2017

1

Unknown

1

All Match

Any Match

Exclude Selected

Exclude Selected

Condition

Laryngopharyngeal reflux

1

All Match

Any Match

Exclude Selected

Exclude Selected

Treatment Modality

Diagnostic

1

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Class

Chemical

2

All Match

Any Match

Exclude Selected

Exclude Selected

Code System

CAS

2

ECHA (EC/EINECS)

2

EPA CompTox

2

FDA UNII

2

NSC

2

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Form

Principal Form

2

All Match

Any Match

Exclude Selected

Exclude Selected

Showing 1 - 2 of 2 results

First page disabled
Previous page disabled
1
Next page disabled
Next page disabled

DIMETHYL SULFITE

9JFA40S66P

Export Data
Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ACHIRAL)

Targets:

sulfite oxidase

Conditions:

Laryngopharyngeal reflux

Dimethyl sulfate (DMS) is a diester of methanol and sulfurous acid. Dimethyl sulfate is a potential reagent for the methylation. It is a substrate for sulfite oxidase. Dimethyl sulfate is stable in blood and can be transported from the intestines to ...

the alveoli and the air. Therefore, DMS in the blood is accepted as a marker of halitosis. The high DMS levels in systemic circulation detected in the multicenter case-control clinical study of laryngopharyngeal reflux.

O-ANISALDEHYDE

7CP821WF2W

Export Data
Search for Structure

Status:

Possibly Marketed Outside US

First approved in 2017

Class (Stereo):

CHEMICAL (ACHIRAL)

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1